{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:57:21Z","timestamp":1793066241504,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31-NS098575"],"award-info":[{"award-number":["F31-NS098575"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R37-NS042925"],"award-info":[{"award-number":["R37-NS042925"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ebiom.2019.03.087","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T11:27:45Z","timestamp":1554982065000},"page":"392-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course"],"prefix":"10.1016","volume":"43","author":[{"given":"Kamilah","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Ntranos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Amatruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Petracca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6940-288X","authenticated-orcid":false,"given":"Johannes","family":"Morstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey T.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Kiebish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Bielekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Katz Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-9264","authenticated-orcid":false,"given":"Patrizia","family":"Casaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.03.087_bb0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0010","article-title":"BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants","volume":"353","author":"Aune","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0015","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2105\/AJPH.2013.301379","article-title":"The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates","volume":"103","author":"Masters","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/CIRCOUTCOMES.113.000702","article-title":"Association of body mass index with increased cost of care and length of stay for emergency department patients with chest pain and dyspnea","volume":"7","author":"Peitz","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-13-424","article-title":"Impact of BMI and BMI change on future drug expenditures in adults: results from the MONICA\/KORA cohort study","volume":"13","author":"Teuner","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-7-242","article-title":"The direct and indirect costs of both overweight and obesity: a systematic review","volume":"7","author":"Dee","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1467-789X.2008.00473.x","article-title":"Obesity and central obesity as risk factors for incident dementia and its sub-types: a systematic review and meta-analysis","volume":"9","author":"Beydoun","year":"2008","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.12.008","article-title":"Obesity-induced cellular senescence drives anxiety and impairs neurogenesis","author":"Ogrodnik","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0045","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","article-title":"Central obesity and increased risk of dementia more than three decades later","volume":"71","author":"Whitmer","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0050","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.59.7.1051","article-title":"Midlife adiposity and the future risk of Parkinson's disease","volume":"59","author":"Abbott","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0055","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000247052.18422.e5","article-title":"Body mass index and the risk of Parkinson disease","volume":"67","author":"Hu","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0060","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1177\/1352458512436596","article-title":"High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women","volume":"18","author":"Hedstr\u00f6m","year":"2012","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0065","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181c0d6e0","article-title":"Body size and risk of MS in two cohorts of US women","volume":"73","author":"Munger","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1352458514546785","article-title":"Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study","volume":"21","author":"Wesnes","year":"2015","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0075","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2014the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0080","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1352458515603798","article-title":"Body mass index during adolescence, rather than childhood, is critical in determining MS risk","volume":"22","author":"Hedstr\u00f6m","year":"2016","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.0b013e31828154f3","article-title":"Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome","volume":"80","author":"Langer-Gould","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0090","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/1352458513483889","article-title":"Childhood body mass index and multiple sclerosis risk: a long-term cohort study","volume":"19","author":"Munger","year":"2013","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/acn3.365","article-title":"Distinct effects of obesity and puberty on risk and age at onset of pediatric MS","volume":"3","author":"Chitnis","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0100","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/j.orcp.2014.01.002","article-title":"Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors","volume":"8","author":"Gianfrancesco","year":"2014","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.msard.2016.05.019","article-title":"Longitudinal BMI trajectories in multiple sclerosis: sex differences in association with disease severity","volume":"8","author":"Bove","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0110","first-page":"181","article-title":"Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis","volume":"87","author":"Kappus","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0115","doi-asserted-by":"crossref","first-page":"e2256","DOI":"10.1212\/WNL.0000000000006644","article-title":"Body mass index, but not vitamin D status, is associated with brain volume change in MS","volume":"91","author":"Mowry","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nut.2013.08.001","article-title":"Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress","volume":"30","author":"Oliveira","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2014.10.020","article-title":"Vascular comorbidities in the onset and progression of multiple sclerosis","volume":"347","author":"Tettey","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00232","article-title":"Association of pre-Disease Body Mass Index with Multiple Sclerosis Prognosis","volume":"9","author":"Manouchehrinia","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0135","doi-asserted-by":"crossref","unstructured":"Paz-Ballesteros WC, Monterrubio-Flores EA, de Jes\u00fas Flores-Rivera J, Corona-V\u00e1zquez T, Hern\u00e1ndez-Gir\u00f3n C. Cigarette smoking, alcohol consumption and overweight in multiple sclerosis: disability progression. Arch Med Res 2017;48:113\u201320. doi:https:\/\/doi.org\/10.1016\/j.arcmed.2017.03.002.","DOI":"10.1016\/j.arcmed.2017.03.002"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0140","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/oby.21448","article-title":"Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans","volume":"24","author":"Tonks","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-543X.2004.00071.x","article-title":"Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes","volume":"5","author":"Goodpaster","year":"2004","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cmet.2012.06.017","article-title":"Sphingolipid signaling in metabolic disorders","volume":"16","author":"Hla","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tem.2008.09.004","article-title":"Sphingolipids: players in the pathology of metabolic disease","volume":"20","author":"Cowart","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000362988","article-title":"Fa\\s sbender K. Sphingolipids: important players in multiple sclerosis","volume":"34","author":"Halmer","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0170","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(68)92510-5","article-title":"Sphingolipids and phospholipids of myelin in multiple sclerosis","volume":"292","author":"Cumings","year":"1968","journal-title":"The Lancet"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0175","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/brain\/awn190","article-title":"A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis","volume":"131","author":"Wheeler","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0180","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/brain\/awu139","article-title":"Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics","volume":"137","author":"Vidaurre","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0185","doi-asserted-by":"crossref","DOI":"10.1042\/CS20180506","article-title":"The relevance of ceramides and their synthesizing enzymes for multiple sclerosis","author":"Kurz","year":"2018","journal-title":"Clin Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molmed.2018.10.009","article-title":"Ceramides as novel disease biomarkers","volume":"25","author":"Kurz","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cmet.2017.12.003","article-title":"Could ceramides become the new cholesterol?","volume":"27","author":"Summers","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cmet.2014.10.017","article-title":"C16: 0-ceramide signals insulin resistance","volume":"20","author":"Hla","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0210","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"192","key":"10.1016\/j.ebiom.2019.03.087_bb0220","first-page":"2551","article-title":"Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases","volume":"1950","author":"Han","year":"2014","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0225","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2R\u03b1-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/metabo6030025","article-title":"Monoacylglycerol analysis using MS\/MS(ALL) quadruple time of flight mass spectrometry","volume":"6","author":"Gao","year":"2016","journal-title":"Metabolites"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mas.20023","article-title":"Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples","volume":"24","author":"Han","year":"2005","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/metabo2010195","article-title":"Shotgun Lipidomics by sequential precursor ion fragmentation on a hybrid quadrupole time-of-flight mass spectrometer","volume":"2","author":"Simons","year":"2012","journal-title":"Metabolites"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-11-587","article-title":"Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis","volume":"11","author":"Du","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0250","first-page":"e22","article-title":"Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes","volume":"45","author":"Zhou","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0255","doi-asserted-by":"crossref","first-page":"r105","DOI":"10.1186\/gb-2013-14-9-r105","article-title":"Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia","volume":"14","author":"Nordlund","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0260","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","article-title":"ChAMP: updated methylation analysis pipeline for Illumina BeadChips","volume":"33","author":"Tian","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nn.3588","article-title":"Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains","volume":"17","author":"Huynh","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0270","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-015-0258-8","article-title":"Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease","volume":"8","author":"Watson","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0275","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/1756-8935-8-6","article-title":"De novo identification of differentially methylated regions in the human genome","volume":"8","author":"Peters","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0285","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1420-9101.2005.00917.x","article-title":"Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach","volume":"18","author":"Whitlock","year":"2005","journal-title":"J Evol Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0290","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0295","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinforma"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0305","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"NeuroImage"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0310","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.neuroimage.2009.09.005","article-title":"A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions","volume":"49","author":"Shiee","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0315","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nature09303","article-title":"Role of Tet proteins in 5mC to 5hmC conversion, ES cell self-renewal, and ICM specification","volume":"466","author":"Ito","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0320","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/1352458515573094","article-title":"Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors","volume":"21","author":"Haines","year":"2015","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1501s77","article-title":"Experimental autoimmune encephalomyelitis in the mouse","author":"Miller","year":"2007","journal-title":"Curr Protoc Immunol Ed John E Coligan Al"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0330","doi-asserted-by":"crossref","DOI":"10.3791\/2348","article-title":"Isolation of brain and spinal cord mononuclear cells using Percoll gradients","author":"Pino","year":"2011","journal-title":"J Vis Exp JoVE"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0335","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cmet.2009.07.011","article-title":"Non-CpG methylation of the PGC-1\u03b1 promoter through DNMT3B controls mitochondrial density","volume":"10","author":"Barr\u00e8s","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1000-6","article-title":"Blood lipids influence DNA methylation in circulating cells","volume":"17","author":"Dekkers","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-016-0243-2","article-title":"The trans fatty acid elaidate affects the global DNA methylation profile of cultured cells and in vivo","volume":"15","author":"Flores-Sierra","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0350","article-title":"Associations between whole peripheral blood fatty acids and DNA methylation in humans","volume":"6","author":"de la Rocha","year":"2016"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0355","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/15592294.2016.1161873","article-title":"Arachidonic and oleic acid exert distinct effects on the DNA methylome","volume":"11","author":"Silva-Martinez","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0360","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1194\/jlr.D008532","article-title":"Blood sphingolipidomics in healthy humans: impact of sample collection methodology","volume":"51","author":"Hammad","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00412","article-title":"Interferon-Beta increases plasma ceramides of specific chain length in multiple sclerosis patients, unlike Fingolimod or Natalizumab","volume":"7","author":"Ottenlinger","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0370","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrg3273","article-title":"Analysing and interpreting DNA methylation data","volume":"13","author":"Bock","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0375","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/blood-2010-12-325381","article-title":"Neurexophilin 1 suppresses the proliferation of hematopoietic progenitor cells","volume":"118","author":"Kinzfogl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0380","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1096\/fj.09-131847","article-title":"The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms","volume":"23","author":"Manni","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0385","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ncb3040","article-title":"\u0394Np63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling","volume":"16","author":"Chakrabarti","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0390","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1474-4422(06)70349-0","article-title":"The measurement and clinical relevance of brain atrophy in multiple sclerosis","volume":"5","author":"Bermel","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0395","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/135245850000600602","article-title":"Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients","volume":"6","author":"Fisher","year":"2000","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0400","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/jnnp-2012-304094","article-title":"Brain atrophy and lesion load predict long term disability in multiple sclerosis","volume":"84","author":"Popescu","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0405","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/1352458513494490","article-title":"Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis","volume":"20","author":"Giorgio","year":"2014","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0410","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1212\/WNL.0000000000001281","article-title":"Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis","volume":"84","author":"Radue","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0415","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1468-1331.2001.00147.x","article-title":"T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study","volume":"8","author":"Sailer","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0420","series-title":"Early Indic Early Treat Neuroprotection Mult Scler","first-page":"135","article-title":"T1-Hypointense lesions (T1 black holes) in mild-to-moderate disability relapsing multiple sclerosis","author":"Simon","year":"2004"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0425","first-page":"2322","article-title":"CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss","volume":"31","author":"Christine","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"194","key":"10.1016\/j.ebiom.2019.03.087_bb0430","first-page":"3917","article-title":"Profiling of the three circulating monocyte subpopulations in human obesity","volume":"1950","author":"Devevre","year":"2015","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/srep42665","article-title":"Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue","volume":"7","author":"Wouters","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0440","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/107602960200800211","article-title":"Postprandial Lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in Normolipemic men","volume":"8","author":"Hyson","year":"2002","journal-title":"Clin Appl Thromb"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0445","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0450","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00125-018-4590-6","article-title":"Ceramide stearic to palmitic acid ratio predicts incident diabetes","volume":"61","author":"Hilvo","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0455","first-page":"995","article-title":"Plasma ceramides are elevated in female children and adolescents with type 2 diabetes","volume":"26","author":"Lopez","year":"2013","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0460","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma Dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans","volume":"18","author":"Wigger","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0465","doi-asserted-by":"crossref","first-page":"102912","DOI":"10.18632\/oncotarget.22076","article-title":"High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism","volume":"8","author":"Braicu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0470","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3892\/or.2015.3973","article-title":"Endocannabinoid and ceramide levels are altered in patients with colorectal cancer","volume":"34","author":"Chen","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0475","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2017.07.143","article-title":"Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer","volume":"147","author":"Knapp","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0480","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cca.2018.02.029","article-title":"Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer","volume":"481","author":"Kozar","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0485","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.21873\/anticanres.11436","article-title":"Altered levels of serum ceramide, sphingosine and sphingomyelin are associated with colorectal Cancer: a retrospective pilot study","volume":"37","author":"Separovic","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/df5af830-8e1d-495a-a206-f881ed85e7fe","article-title":"Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans","volume":"9","author":"Radner","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091769","article-title":"Sphingolipids in human synovial fluid - a Lipidomic study","volume":"9","author":"Kosinska","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0500","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.joca.2016.03.017","article-title":"Comparative lipidomic analysis of synovial fluid in human and canine osteoarthritis","volume":"24","author":"Kosinska","year":"2016","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0505","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","article-title":"Plasma sphingomyelin level as a risk factor for coronary artery disease","volume":"20","author":"Jiang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0510","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0515","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma Ceramides","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0520","first-page":"357","article-title":"Ceramide is upregulated and associated with mortality in patients with chronic heart failure","volume":"31","author":"Yu","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0525","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0530","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2017.08.026","article-title":"Serum lipid alterations in GBA-associated Parkinson's disease","volume":"44","author":"Guedes","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073094","article-title":"Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study","volume":"8","author":"Mielke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0540","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2016.09.028","article-title":"Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia","volume":"370","author":"Xing","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0545","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J Alzheimers Dis JAD"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0550","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-160645","article-title":"Association between plasma ceramides and phosphatidylcholines and hippocampal brain volume in late onset Alzheimer's disease","volume":"60","author":"Kim","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0555","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jalz.2010.03.014","article-title":"Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss","volume":"6","author":"Mielke","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0560","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2011-110405","article-title":"Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease","volume":"27","author":"Mielke","year":"2011","journal-title":"J Alzheimers Dis JAD"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0565","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0570","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0575","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","article-title":"Many ceramides","volume":"286","author":"Hannun","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0580","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2003.08.020","article-title":"Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes","volume":"419","author":"Chavez","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0585","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","article-title":"Lipid composition of the normal human brain: gray matter, white matter, and myelin","volume":"6","author":"O'Brien","year":"1965","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0590","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)39620-6","article-title":"Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin","volume":"6","author":"O'Brien","year":"1965","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0595","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12017-010-8128-4","article-title":"Sphingolipids in multiple sclerosis","volume":"12","author":"Jana","year":"2010","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0600","doi-asserted-by":"crossref","first-page":"21807","DOI":"10.1073\/pnas.0906891106","article-title":"Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis","volume":"106","author":"Kihara","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2008.12.010","article-title":"Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death","volume":"278","author":"Jana","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0610","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","article-title":"Ceramide function in the brain: when a slight tilt is enough","volume":"70","author":"Mencarelli","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0615","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2217\/17460875.3.3.273","article-title":"Ceramide signaling in cancer and stem cells","volume":"3","author":"Bieberich","year":"2008","journal-title":"Future Lipidol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0620","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI0216127","article-title":"The therapeutic potential of modulating the ceramide\/sphingomyelin pathway","volume":"110","author":"Kolesnick","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0625","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.bbamem.2011.01.007","article-title":"Visualization of ceramide channels by transmission Electron microscopy","volume":"1808","author":"Samanta","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0630","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1194\/jlr.M700480-JLR200","article-title":"Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins","volume":"49","author":"Stiban","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0635","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00702-017-1795-7","article-title":"Differential contribution of microglia and monocytes in neurodegenerative diseases","volume":"125","author":"Baufeld","year":"2018","journal-title":"J Neural Transm"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00234","article-title":"Lessons learned about neurodegeneration from microglia and monocyte depletion studies","volume":"9","author":"Lund","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0645","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awv395","article-title":"Immunosenescence of microglia and macrophages: impact on the ageing central nervous system","volume":"139","author":"Rawji","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0650","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/brain\/123.6.1174","article-title":"Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation","volume":"123","author":"Bitsch","year":"2000","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0655","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneurol.2016.110","article-title":"Myeloid cells \u2014 targets of medication in multiple sclerosis","volume":"12","author":"Mishra","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0660","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Niki\u0107","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0665","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2019.03.087_bb0670","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneuroim.2015.11.004","article-title":"Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis","volume":"290","author":"Moreno","year":"2016","journal-title":"J Neuroimmunol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:58:07Z","timestamp":1762455487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419302324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":133,"alternative-id":["S2352396419302324"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.087","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}